📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. (2020)

First Author: Hughes RE

Attributed to: MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2472555220917115

PubMed Identifier: 32441181

Publication URI: http://europepmc.org/abstract/MED/32441181

Type: Journal Article/Review

Volume: 25

Parent Publication: SLAS discovery : advancing life sciences R & D

Issue: 7

ISSN: 2472-5552